Rekonnect has raised 4.6 MSEK in a successful pre-seed funding round with Curus as the largest investor. This marks a major milestone and puts the company in a great position to execute on its ambitious plan to revolutionize post-market surveillance for medical technology companies.

Rekonnect was established by a seasoned group of business and technology experts with a vision to create a groundbreaking solution that will disrupt the fast-evolving medical technology industry and healthcare industry. Capitalizing on the critical need for medical device manufacturers to comply with regulations, Rekonnect offers a vital solution for evaluating the post-market impact of medical devices.

By optimizing workflows and processes that improve the overall performance of medical devices, Rekonnect brings together the key players in the MedTech world by creating a secure, centralized digital ecosystem.

– We saw that selling medical devices through global distributors created a disconnect that left device-users isolated from essential support, also customer data and device usability insights owned by distributors. We are on a mission to digitally transform and centralize the device data and user insights, and ensure companies meet MDR regulations, says Will Gray, Co-founder and CEO.

Rekonnect empowers healthcare professionals, resellers, distributors, and medical technology manufacturers to effortlessly exchange valuable data, fostering a collaborative environment that drives innovation and improves patient outcomes.

Investors in the pre-seed round comprised of Curus, LOOP Capital, Fast Track Capital, and Angcell Ventures, along with several notable angel investors including Ingela Hallberg, Emil Sjödin, and Björn Andersson. The funding will be used to further develop the platform, acquire customers, and expand the core team.

– Will and his team have developed a great platform with a clear market fit that can easily scale internationally. We are thrilled to be part of the extended Rekonnect team as investors, helping the team in the best way we can to build a leading global platform for post-market surveillance of medical devices, says Erik Olsson Nyrén, Investment Manager at Curus.

Rekonnect is already attracting widespread interest from a wide range of potential customers and partners within Europe, and the funding will aid the company in ramping up its growth. It is confident that its distinctive approach will resonate with customers whilst distinguishing it from the competition.

 

For more information:
Erik Olsson Nyrén, Investment Manager Curus
[email protected], +46 708 37 73 54

Will Gray, Co-founder & CEO Rekonnect
[email protected], +46 700 37 21 93

 

About Rekonnect
Rekonnect is B2B SaaS solution designed for medical technology companies to achive post-market success. Rekonnect provides advanced stakeholder relationship management, device information management, service management and more. For more information, visit Rekonnect.

About Curus
Curus is a Nordic-based, investment company focused on investments in the healthcare and health related sector. Curus has made around 25 investments to date, both minority and majority investments, backing exceptional entrepreneurs. Our mission is to support the best entrepreneurs with our network, knowledge, marketing, strategic advice and capital to create long-term value. For more information, visit Curus.